$REGN

$961.26▲ +3.5% YTD

11 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

News

REGN ▲ +3.5% - Regeneron Pharmaceuticals, Inc.

CP $961.26▲ +3.5%Nov 2, 2026 · ThinkSabio Blog

$REGN - Regeneron Announces Investor Conference Presentations…

News

REGN ▼ -0.2% - Regeneron Pharmaceuticals, Inc.

CP $927.00▲ -0.2%Nov 2, 2026 · ThinkSabio Blog

$REGN pt 1050 @ BMO from 920…

News

REGN ▲ +2.0% - Regeneron Pharmaceuticals, Inc.

CP $835.00▲ +2.0%Oct 30, 2026 · ThinkSabio Blog

$REGN Regeneron Q3 earnings beat — Revenue $5.1B vs $4.54B expected, up 36% YoY — Adj. EPS $20.07 vs $16.24 expected, up 70% YoY — Dupixent global net…

News

REGN ▲ +2.0% - Regeneron Pharmaceuticals, Inc.

CP $835.00▲ +2.0%Oct 30, 2026 · ThinkSabio Blog

$REGN - Regeneron Reports Third Quarter 2026 Financial and Operating Results…

News

REGN ▼ -0.1% - Regeneron Pharmaceuticals, Inc.

CP $804.00▲ -0.1%Oct 26, 2026 · ThinkSabio Blog

$REGN - Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. Preparedness…

News

REGN ▼ -1.8% - Regeneron Pharmaceuticals, Inc.

CP $804.00▲ -1.8%Oct 25, 2026 · ThinkSabio Blog

$REGN - Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk…

News

REGN ▲ +2.2% - Regeneron Pharmaceuticals, Inc.

CP $763.98▲ +2.2%Oct 12, 2026 · ThinkSabio Blog

$REGN - Pasatru™ (garetosmab-grts) Demonstrates Zero New Heterotopic Ossification (HO) Lesions in Adult Fibrodysplasia Ossificans Progressiva (FOP) Pa…

News

REGN ▼ -3.3% - Regeneron Pharmaceuticals, Inc.

CP $732.59▲ -3.3%Oct 1, 2026 · ThinkSabio Blog

$REGN - Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSO…

News

REGN ▼ -3.2% - Regeneron Pharmaceuticals, Inc.

CP $733.95▲ -3.2%Oct 1, 2026 · ThinkSabio Blog

$REGN - Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss…

News

REGN ▲ +1.1% - Regeneron Pharmaceuticals, Inc.

CP $759.00▲ +1.1%Oct 1, 2026 · ThinkSabio Blog

$REGN - Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies…

News

REGN ▼ -0.7% - Regeneron Pharmaceuticals, Inc.

CP $796.02▲ -0.7%Sep 24, 2026 · ThinkSabio Blog

$REGN - Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026…